Standardizing care for hepatitis delta in the Netherlands
Standardising Care for Hepatitis Delta in the Netherlands
This study is trying to gather information from adults with hepatitis delta to better understand the disease and improve how it's treated.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 80 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Erasmus Medical Center Academic / other |
| Locations | 1 site (Rotterdam) |
| Trial ID | NCT05903742 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather prospective follow-up data on patients with hepatitis delta, a rare and severe liver disease associated with hepatitis B virus. Over a five-year period, the study will collect standard clinical data, blood samples, and quality of life questionnaires from participants aged 18 and older. The goal is to enhance understanding of hepatitis delta and improve management practices, which currently vary due to the low incidence of the disease.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have active hepatitis delta confirmed by specific blood tests.
Not a fit: Patients without active hepatitis delta or those under 18 years old may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved care and management strategies for patients with hepatitis delta.
How similar studies have performed: While there is limited experience in managing hepatitis delta due to its rarity, this study aims to standardize care practices, which could be a novel approach in this field.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Active hepatitis delta based on a positive anti-HDV and a positive HDV-RNA test * Patients must be ≥18 years * Written informed consent Exclusion Criteria: * None
Where this trial is running
Rotterdam
- Erasmus MC — Rotterdam, Netherlands (Recruiting)
Study contacts
- Study coordinator: Lesley Patmore, MD
- Email: l.patmore@erasmusmc.nl
- Phone: +31629677982
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.